Katharina Luise Hupa-Breier
Overview
    Explore the profile of Katharina Luise Hupa-Breier including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              6
            
            
              Citations
              33
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Campos-Murguia A, Hupa-Breier K, Hartleben B, Wedemeyer H, Taubert R, Engel B
  
  
    Transplant Direct
    . 2025 Jan;
          10(3):e1592.
    
    PMID: 39877649
  
  
          Background: The noninvasive detection of subclinical graft injury including subclinical T cell-mediated rejection (subTCMR) is one of the unresolved challenges after liver transplantation. Recently, serum C-X-C motif chemokine ligand 8...
      
2.
        
    
    Campos-Murguia A, Guetzlaff L, Bosselmann E, Engel B, Hartleben B, Wedemeyer H, et al.
  
  
    Clin Transplant
    . 2024 Nov;
          38(11):e70039.
    
    PMID: 39575514
  
  
          Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading indication for liver transplantation (LT), but also occurs after LT. The prevalence of de novo MASLD (dnMASLD) after...
      
3.
        
    
    Engel B, Diestelhorst J, Hupa-Breier K, Kirchner T, Henjes N, Loges S, et al.
  
  
    Hepatol Int
    . 2024 Jul;
          18(4):1214-1226.
    
    PMID: 38976227
  
  
          Objective: The detection of autoantibodies is essential to diagnose autoimmune hepatitis (AIH). Particularly in children, specificity of autoantibodies decreases due to lower titers being diagnostic and being present not only...
      
4.
        
    
    Wranke A, Heidrich B, Deterding K, Hupa-Breier K, Kirschner J, Bremer B, et al.
  
  
    Hepatol Int
    . 2023 Oct;
          17(6):1359-1367.
    
    PMID: 37789170
  
  
          Background And Aims: Hepatitis D virus (HDV) infection causes the most severe form of chronic viral hepatitis. However, it is still unclear to what extent the underlying cirrhosis may contribute...
      
5.
        
    
    Hupa-Breier K, Dywicki J, Hartleben B, Wellhoner F, Heidrich B, Taubert R, et al.
  
  
    Biomedicines
    . 2021 Apr;
          9(4).
    
    PMID: 33808404
  
  
          Dysregulation of glucose homeostasis plays a major role in the pathogenesis of non-alcoholic steatohepatitis (NASH) as it activates proinflammatory and profibrotic processes. Beneficial effects of antiglycemic treatments such as GLP-1...
      
6.
        
    
    Hupa-Breier K, Taubert R, Jaeckel E, Manns M
  
  
    Aliment Pharmacol Ther
    . 2018 Nov;
          48(11-12):1315-1316.
    
    PMID: 30488627
  
  
          No abstract available.
      
7.
        
    
    Taubert R, Hupa-Breier K, Jaeckel E, Manns M
  
  
    J Autoimmun
    . 2018 Nov;
          95:34-46.
    
    PMID: 30401504
  
  
          Autoimmune hepatitis (AIH) is an orphan disease characterized by an autoimmune attack against hepatocytes. The exact sequence of events that leads to a breach of tolerance is incompletely understood. Current...